Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
USP8 in cancer resistance USP8 emerges as a key regulator of cancer therapy resistance, modulating the efficacy of anti-PD-1/PD-L1 immunotherapy, targeted agents, and diverse chemotherapeutics through distinct molecular mechanisms
doi: 10.1016/j.chest.2020.07.023 48 CuadradoA.PajaresM.BenitoC.Jimnez-VillegasJ.EscollM.Fernndez-Ginset al
Using this technique, we found a significant increase in NO levels and a reprogramming of the SNO-proteome in the brain of Shank3 InsG3680 (+/+) mouse model of ASD [171]
StatPearls NCBI Bookshelf
Choudhury KN, Mainuddin AK, Wahiduzzaman M, Islam SM
US$ 26.30
US$ 21.95
US$ 22.52
US$ 21.73
US$ 21.52
